Biblio Discovery — Demo Discovery Service

3 results for "Mark-David Levin"

Showing 1–3 · 0.49 seconds · RSS

  1. Journal Article Full text

    Autologous haematopoietic stem-cell transplantation versus bortezomib–melphalan–prednisone, with or without bortezomib–lenalidomide–dexamethasone consolidation therapy, and lenalidomide maintenance for newly diagnosed multiple myeloma (EMN02/HO95): a multicentre, randomised, open-label, phase 3 study

    Michèle Cavo; Francesca Gay; Meral Beksaç et al.

    The Lancet Haematology · 2020 · English · OpenAlex Scopus

    Background The emergence of highly active novel agents has led some to question the role of autologous haematopoietic stem-cell transplantation (HSCT) and subsequent consolidation therapy in newly diagnosed multiple myeloma. We therefore compared autologous HSCT with bortezomib–melphalan–prednisone…

  2. Journal Article Full text

    First-Line Venetoclax Combinations in Chronic Lymphocytic Leukemia

    Barbara F. Eichhorst; Carsten Utoft Niemann; Arnon Philip Kater et al.

    New England Journal of Medicine · 2023 · English · OpenAlex Scopus

    Randomized trials of venetoclax plus anti-CD20 antibodies as first-line treatment in fit patients (i.e., those with a low burden of coexisting conditions) with advanced chronic lymphocytic leukemia (CLL) have been lacking. Download a PDF of the Research Summary. In a phase 3, open-label trial, we…